Evidence map›Paper›PMID 25255318›Full record

ArticlePLoS computational biology2014

Characterizing protein interactions employing a genome-wide siRNA cellular phenotyping screen.

Apichat Suratanee, Martin H Schaefer, Matthew J Betts, Zita Soons, Heiko Mannsperger, Nathalie Harder, Marcus Oswald, Markus Gipp, Ellen Ramminger, Guillermo Marcus and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Apichat SurataneeDepartment of Mathematics, Faculty of Applied Science, King Mongkut's University of Technology North Bangkok, Bangsue, Bangkok, Thailand.
Martin H SchaeferEMBL/CRG Systems Biology Research Unit, Center for Genomic Regulation, Barcelona, Spain.
Matthew J BettsRobert B. Russell, Cell Networks Protein Evolution, BioQuant, University of Heidelberg, Heidelberg, Germany.
Zita SoonsNetwork Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Jena, Germany; Department of Knowledge Engineering, Maastricht University, Maastricht, The Netherlands; Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
Heiko MannspergerTheoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
Nathalie HarderTheoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, BioQuant, University of Heidelberg, Heidelberg, Germany.
Marcus OswaldNetwork Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
Markus GippDepartment of Computer Science V, Institute of Computer Engineering, University of Mannheim, Mannheim, Germany.
Ellen RammingerAG Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Guillermo MarcusDepartment of Computer Science V, Institute of Computer Engineering, University of Mannheim, Mannheim, Germany.
Reinhard MännerDepartment of Computer Science V, Institute of Computer Engineering, University of Mannheim, Mannheim, Germany.
Karl RohrTheoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, BioQuant, University of Heidelberg, Heidelberg, Germany.
Erich WankerAG Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Robert B RussellRobert B. Russell, Cell Networks Protein Evolution, BioQuant, University of Heidelberg, Heidelberg, Germany.
Miguel A Andrade-NavarroComputational Biology and Data Mining Group, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Roland EilsTheoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, BioQuant, University of Heidelberg, Heidelberg, Germany.
Rainer KönigNetwork Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany; Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
German Cancer Research Center · DEHeidelberg University · DEMax Delbrück Center · DEUniversity of Mannheim · DEJena University Hospital · DECentre for Genomic Regulation · ESKing Mongkut's University of Technology North Bangkok · THLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterizing the activating and inhibiting effect of protein-protein interactions (PPI) is fundamental to gain insight into the complex signaling system of a human cell. A plethora of methods has been suggested to infer PPI from data on a large scale, but none of them is able to characterize the effect of this interaction. Here, we present a novel computational development that employs mitotic phenotypes of a genome-wide RNAi knockdown screen and enables identifying the activating and inhibiting effects of PPIs. Exemplarily, we applied our technique to a knockdown screen of HeLa cells cultivated at standard conditions. Using a machine learning approach, we obtained high accuracy (82% AUC of the receiver operating characteristics) by cross-validation using 6,870 known activating and inhibiting PPIs as gold standard. We predicted de novo unknown activating and inhibiting effects for 1,954 PPIs in HeLa cells covering the ten major signaling pathways of the Kyoto Encyclopedia of Genes and Genomes, and made these predictions publicly available in a database. We finally demonstrate that the predicted effects can be used to cluster knockdown genes of similar biological processes in coherent subgroups. The characterization of the activating or inhibiting effect of individual PPIs opens up new perspectives for the interpretation of large datasets of PPIs and thus considerably increases the value of PPIs as an integrated resource for studying the detailed function of signaling pathways of the cellular system of interest.

Indexed as

Cluster AnalysisDatabases, ProteinGene Knockdown TechniquesGenomicsHeLa CellsHumansPhenotypeProtein Interaction MapsProteinsRNA, Small InterferingROC CurveProteinsRNA, Small Interfering

Identifiers

PMID25255318
PMCPMC4178005
OpenAlexW2110582765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.